How Big is the Diabetic Retinopathy Market | Growth Insight 2025

Q: What is the market size of the diabetic retinopathy market in 2025 and 2031?

The diabetic retinopathy market was valued at USD 8.2 billion in 2024 and is expected to reach USD 13.9 billion by 2031.

Q: What is the CAGR of the diabetic retinopathy market between 2025 and 2031?

The diabetic retinopathy market is expected to grow at a CAGR of 6.79% during the forecast period.

Q: What are the key trends in the diabetic retinopathy market?

Key trends include adoption of AI diagnostics, rise in minimally invasive treatments, focus on personalized medicine, and expanding telemedicine applications.

Q: What are the main drivers of the diabetic retinopathy market?

The diabetic retinopathy market is primarily driven by the rising diabetic population, early detection and screening innovations, favorable healthcare policies.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6006

Publication Date: Jul 2025

What is the diabetic retinopathy Market Size?

According to 6Wresearch internal database and industry insights, the Global Diabetic retinopathy market was valued USD 8.2 billion in 2024 and is expected to reach USD 13.9 billion by 2031, registering a steady at a CAGR of 6.79% during the forecast period.

This market is witnessing significant growth due to the rising prevalence of diabetes globally, increasing awareness of diabetic eye complications, and growing investment in advanced ophthalmic diagnostics and therapeutics. Technological innovations, improved screening techniques, and early detection methods are further propelling the market. Additionally, favorable reimbursement policies and growing access to healthcare in emerging economies are playing a pivotal role in market expansion.

View Main Report

Schedule Analyst Call

Major Growth Factors of the Diabetic Retinopathy Market

Rising global prevalence of diabetes
Increasing awareness about diabetic eye diseases
Advancements in retinal imaging and diagnostics
Growing investments in ophthalmic research and therapies
Expansion of healthcare access in emerging countries
Favorable reimbursement policies for retinal treatments
Rising adoption of anti-VEGF therapies
Technological improvements in laser treatments and intraocular implants

Diabetic Retinopathy Market Trends

The diabetic retinopathy market is witnessing robust growth due to the integration of artificial intelligence (AI) in retinal screening, as well as the development of minimally invasive treatment approaches. There is also a significant rise in public-private collaborations for diabetic eye care programs. Moreover, a shift toward personalized medicine and gene-based therapy is emerging as a key trend in the market.

Emerging Developments in the Diabetic Retinopathy Market

Diabetic retinopathy market emerges with the innovative launch of AI-powered diagnostic tools, approval of longer-acting intravitreal injections, and advancements in gene therapy. Companies are increasingly focusing on combining diagnostics with therapeutic delivery systems to enhance efficacy. The development of tele-retinal screening tools is also expanding patient outreach in rural and underdiagnosed populations.